| 引用本文:丁亚丛1，杨宇飞1，王萌萌1，唐末2，王妍松3，何斌1.《Ⅰ-Ⅲ期结直肠癌西医常规治疗后中医干预指南》解读及病例分享[J].世界中医药,2023,(11):. |
|
| 《Ⅰ-Ⅲ期结直肠癌西医常规治疗后中医干预指南》解读及病例分享 |
| Interpretation and A Medical Case of the Guideline for Traditional Chinese Medicine Intervention after Conventional Western Medicine Treatment of Stage Ⅰ-Ⅲ Colorectal Cancer |
| 投稿时间：2023-04-10 |
| DOI：10.3969/j.issn.1673-7202.2023.11.003 |
| 中文关键词: 早中期 结直肠癌 西医常规治疗 中医 方案 指南解读 病例分享 循证 |
| English Keywords:Stage Ⅰ-Ⅲ Colorectal cancer Conventional western medicine treatment Traditional Chinese medicine Protocols Interpretation of guideline Medical case sharing Evidence-based practice |
| 基金项目:国家自然科学基金项目（81973676）——基于Wnt/β-catenin调控的干细胞再生探索中医健脾补肾序贯疗法改善化疗所致消化道及骨髓毒性的机制研究；国家中医药管理局——2019年重大疑难疾病中西医临床协作能力建设项目（结直肠癌）［国中医药办医政函(2018)275］ |
|
| 摘要点击次数: 464 |
| 全文下载次数: 0 |
| 中文摘要: |
| 《Ⅰ-Ⅲ期结直肠癌西医常规治疗后中医干预指南》于2020年3月9日在中华中医药学会立项，由来自全国各地12家单位组成的18名专家起草，2022年7月正式在中华中医药学会发布。本指南通过德尔菲法确定了5个临床问题并通过循证医学进行了解答。结直肠癌是常见的恶性肿瘤之一，其较高的发病率与不良生活方式、饮食结构和环境的改变有关。中医药对于Ⅰ-Ⅲ期结直肠癌的治疗积累了大量临床经验，具有独特疗效，已有大量研究表明中医可作为结直肠癌西医常规治疗后的补充和替代治疗，为进一步规范Ⅰ-Ⅲ期结直肠癌西医常规治疗后的中医诊疗，提高中医诊治Ⅰ-Ⅲ期结直肠癌的水平，使其具有良好的科学性及适用性，中国中医科学院西苑医院联合全国多家单位共同制定了本指南。为了提高本指南的适用性，方便临床医生应用，现对发病机制、诊断、辨证分型、治疗及临床问题等内容进行解读，并通过1例典型病例解读指南的临床问题产生过程。由本指南制定相关专家及参与工作的医学生组成的研究团队对该指南进行解读。参与指南解读的人员不存在与原指南相关的学术或商业利益冲突。 |
| English Summary: |
| The Guideline for Traditional Chinese Medicine Intervention after Conventional Western Medicine Treatment for Stage Ⅰ-Ⅲ Colorectal Cancer，initiated by the China Association of Chinese Medicine on March 9，2020，was drafted by 18 experts from 12 institutions in China and officially released by the China Association of Chinese Medicine in July 2022.This guideline used the Delphi method to identify five clinical questions and provided evidence-based answers.Colorectal cancer is a common malignant tumor，and its high incidence is related to poor lifestyle，dietary changes，and environmental factors.Traditional Chinese medicine(TCM) has accumulated extensive clinical experience in the treatment of stage Ⅰ-Ⅲ colorectal cancer and has shown unique therapeutic effects.Numerous studies have demonstrated that TCM can be used as a complementary and alternative treatment after conventional western medicine for colorectal cancer.In order to standardize the TCM diagnosis and treatment for stage Ⅰ-Ⅲ colorectal cancer after conventional western medicine treatment and improve its scientific level and applicability，Xiyuan Hospital of China Academy of Chinese Medical Sciences，in collaboration with multiple institutions nationwide，jointly developed this guideline.To enhance the applicability of this guideline and facilitate its use by clinical practitioners，the mechanism of onset，diagnosis，syndrome differentiation，treatment，and clinical issues were interpreted.Additionally，the generation of the clinical questions in the guideline was illustrated using a typical medical case.A research team composed of experts involved in the development of the guideline and medical students participated in the interpretation.There were no academic or commercial conflicts of interest among the personnel involved in the interpretation of the guideline. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
